EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Pre‐polycystic ovary syndrome and polymenorrhoea as new facets of polycystic ovary syndrome (PCOS): Evidences from a single centre data set

Mohd Ashraf Ganie iD, Aafia Rashid, Mohammad Salem Baba, Mohd Afzal Zargar, Imtiyaz Ahmad Wani, Sobia Nisar, Ishfaq Ahmad Wani, Syed Douhath, Mukesh Sriwastawa, Mohd Ishaq Geer, Mir Mohd Asrar, Rintu Kutum und 15 weitere

Clinical Endocrinology · 2023

DOI: 10.1111/cen.14964 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical Endocrinology, 2023. Verfasst von Mohd Ashraf Ganie und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Sheri-Kashmir Institute of Medical Sciences, Srinagar, India. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Hyperandrogenism. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India, Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Polycystic ovary syndrome (PCOS) is a complex disorder with diverse metabolic implications. Diagnosis typically relies on oligo‐amenorrhoea (OA), hyperandrogenism (HA), and polycystic ovarian morphology (PCOM). However, the role of polymenorrhoea in PCOS remains understudied. Additionally, limited information exists regarding metabolic disturbances in women with partial PCOS phenotypes that do not meet diagnostic criteria. This extensive database aims to provide substantial evidence on the metabolic implications of polymenorrhoea and partial PCOS phenotypes.

Design

Prospective observational study. Patients and Measurements In this single‐centre study, 6463 women with PCOS‐like characteristics and 3142 age‐matched healthy women were included. The study compared clinical (anthropometry, modified Ferriman Gallwey [mFG] score), hormonal (serum testosterone), and metabolic (plasma glucose, serum lipids, insulin) characteristics between women diagnosed with PCOS, those with partial PCOS phenotypes, and the healthy control group Results In all, 5174 women met Rotterdam criteria for PCOS diagnosis, while 737 were classified as Pre‐PCOS, including HA ( n = 538), OA ( n = 121), or PCOM ( n = 78). Common clinical features included oligomenorrhoea (75.5%), hirsutism (82.9%), obesity (27.2%), hypertension (1.6%), metabolic syndrome (19.6%), and diabetes mellitus (5.6%). Women diagnosed with PCOS, HA only, and OA only exhibited higher average body mass index, plasma glucose levels (both fasting and 2 h after the oral glucose tolerance test), and lipid fractions in comparison to those with PCOM and the healthy controls. However, indices of insulin resistance were similar among women with PCOS, HA, PCOM, and OA, albeit higher than in the healthy controls. The polymenorrhoea subgroup (5.9%) had lower BMI and serum testosterone, but similar mFG score, plasma glucose, insulin, and lipid levels as the oligomenorrhoea subgroup.

Conclusion

The metabolic disturbances observed in Pre‐PCOS women highlight the need to reassess diagnostic criteria. Including the polymenorrhoea subcategory in PCOS criteria is recommended due to similar metabolic dysfunctions as the oligomenorrhoea group.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeHyperandrogenismFemaleHumansOligomenorrheaBlood GlucoseInsulinTestosteroneLipids

Stichwörter der Autor:innen

IndiaPCOSPre-PCOSmetabolismoligomenorrhoeaphenotypepolymenorrhoea

Substanzen

Blood GlucoseInsulinTestosteroneLipids

Autor:innen und Institutionen

  • Department of Endocrinology, Sheri-Kashmir Institute of Medical Sciences, Srinagar, India.
  • Department of Clinical Research, Sheri-Kashmir Institute of Medical Sciences, Srinagar, India.
  • Department of Life Sciences, Central University of Kashmir, Ganderbal, India.
  • Department of Medicine, Government Medical College, Srinagar, India.
  • Department of Microbiology and Immunology, University of Louisville, Louisville, Kentucky, USA.
  • Department of Pharmacology, University of Kashmir, Srinagar, India.

ORCID-Profile: Mohd Ashraf Ganie

Förderung

  • Department of Biotechnology, Ministry of Science and Technology, India
  • Indian Council of Medical Research

Zitieren

APA

Ganie, M. A., Rashid, A., Baba, M. S., Zargar, M. A., Wani, I. A., Nisar, S., Wani, I. A., Douhath, S., Sriwastawa, M., Geer, M. I., Asrar, M. M., Kutum, R., Hassan, S., Khan, S., Rafi, W., Bhat, D. A., Showkat, W., Sahar, T., Choh, N. A., …, & Sreenivas, V. (2023). Pre‐polycystic ovary syndrome and polymenorrhoea as new facets of polycystic ovary syndrome (PCOS): Evidences from a single centre data set. Clinical Endocrinology. https://doi.org/10.1111/cen.14964

Vancouver

Ganie MA, Rashid A, Baba MS, Zargar MA, Wani IA, Nisar S, et al. Pre‐polycystic ovary syndrome and polymenorrhoea as new facets of polycystic ovary syndrome (PCOS): Evidences from a single centre data set. Clinical Endocrinology. 2023. doi:10.1111/cen.14964

BibTeX
@article{Ganie2023,
  author = {Ganie, Mohd Ashraf and Rashid, Aafia and Baba, Mohammad Salem and Zargar, Mohd Afzal and Wani, Imtiyaz Ahmad and Nisar, Sobia and Wani, Ishfaq Ahmad and Douhath, Syed and Sriwastawa, Mukesh and Geer, Mohd Ishaq and Asrar, Mir Mohd and Kutum, Rintu and Hassan, Saqib and Khan, Shahid and Rafi, Wajid and Bhat, Dil Afroz and Showkat, Wasia and Sahar, Tajali and Choh, Naseer Ahmad and Khurshid, Rabia and Mudassar, Syed and Shah, Zafar Amin and Shabir, Iram and Sofi, Sanjeed Ahmad and Gupta, Nandita and Hafeez, Imran and Sreenivas, Vishnubatla},
  title = {Pre‐polycystic ovary syndrome and polymenorrhoea as new facets of polycystic ovary syndrome (PCOS): Evidences from a single centre data set},
  journal = {Clinical Endocrinology},
  year = {2023},
  doi = {10.1111/cen.14964}
}
Kostenlos starten →